Friday, March 28, 2014

Maryland Senate holds hearing on Compounding Legislation

Health Occupations - Compound Drugs - Provision to Ophthalmologists for Office Use

Sponsored by:

Delegate Morhaim


In the Senate - Hearing 3/27 at 1:00 p.m.

Synopsis:Authorizing a pharmacy for which a pharmacy permit has been issued by the State Board of Pharmacy and a sterile compounding facility to provide to an ophthalmologist for office use, without a patient-specific prescription, specified compound drugs for specified purposes; requiring the pharmacy or sterile compounding facility to require the ophthalmologist to provide to the pharmacy or sterile compounding facility the identity of any patient to whom the drugs are administered; etc.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Delegates Morhaim, Bromwell, Costa, Cullison, Donoghue, Elliott, Hammen, Hubbard, Kach, A. Kelly, Kipke, Krebs, McDonough, Murphy, Nathan-Pulliam, Pena-Melnyk, Pendergrass, Ready, Reznik, Tarrant, and V. Turner
Additional Facts:Bill File Type: Regular
Effective Date(s): July 1, 2014
Health and Government Operations   View Committee HearingEducation, Health, and Environmental Affairs   Listen to Committee Hearing
Broad Subject(s):Health Occupations
Narrow Subject(s):Committees and Commissions -see also- Political Committees
Drugs -see also- Controlled Dangerous Sub; Substance Abuse
Emergency Medical Services
Federal Government
Pharmacists and Pharmacies
Statutes:Article - Health Occupations
(12-403, 12-4A-12)

No comments: